{"id":108,"date":"2018-11-30T14:24:45","date_gmt":"2018-11-30T14:24:45","guid":{"rendered":"https:\/\/admin.innaxon.co.uk\/?page_id=108"},"modified":"2018-11-30T14:28:29","modified_gmt":"2018-11-30T14:28:29","slug":"monophosphoryl-lipid-a-mpla-bio-synthetic-from-s-minnesota-r595-re-tlrpure-sterile-solution","status":"publish","type":"page","link":"https:\/\/wp.innaxon.co.uk\/?page_id=108","title":{"rendered":"Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution"},"content":{"rendered":"<p><strong>Product Size<\/strong><\/p>\n<p>250\u00b5g:\u00a0\u00a3<span id=\"_EKM_PRODUCTPRICE\">100.91<\/span><\/p>\n<p>500\u00b5g: \u00a3<span id=\"_EKM_PRODUCTPRICE\">134.55<\/span><\/p>\n<p>1mg: \u00a3<span id=\"_EKM_PRODUCTPRICE\">201.82<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Product Number<\/strong><\/p>\n<p>250\u00b5g: IAX-100-002-C250<\/p>\n<p>500\u00b5g: IAX-100-002-C500<\/p>\n<p>1mg: IAX-100-002-M001<\/p>\n<p>&nbsp;<\/p>\n<p><b>Source <\/b><br \/>\nMonophosphoryl Lipid A [MPLA] derived from <i>S. minnesota <\/i>R595 (Re) TLRpure\u2122 LPS (bio-synthetic).<\/p>\n<p><b>TLRpure\u2122 <\/b><br \/>\nNo detectable TLR4 <i>independent <\/i>activity: standardised potent TLR4-specific agonist.<\/p>\n<p><b>Purity <\/b><br \/>\n\u226599.9%. No detectable DNA, RNA and protein traces.<\/p>\n<p><b>Purification Method <\/b><br \/>\nR-form (mutant\/rough) LPS was isolated by phenol-chloroform-petroleum-ether method. Semi-purified LPS was subjected to further re-extraction cycles and ultracentrifugation steps, extensively electrodialysed before converted to its uniform sodium salt form to yield TLRpure\u2122 LPS, from which MPLA was generated by acid hydrolysis.<\/p>\n<p><b>Concentration\u00a0\u00a0 <\/b><br \/>\n1mg\/ml (0.5mg\/ml for 250\u03bcg size) stabilised in sterile, double-distilled water (ddWater), without any additives.<\/p>\n<p><b>Biological Activity <\/b><br \/>\nOptimal concentration is dependent upon cell type, species, desired activation and analysis: 0.1-1.0\u03bcg\/ml. Does not activate any TLR other than TLR4 as tested up to 50\u03bcg\/ml in relevant cellular systems (macrophages).<\/p>\n<p><b>Shipping\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/b><br \/>\nAMBIENT<\/p>\n<p><b>Storage <\/b><br \/>\n+4\u00b0C<\/p>\n<p><b>Handling Advice <\/b><br \/>\nDo not freeze. Prepare diluted MPLA working solutions in water just prior to use, keep sterile. Do <b><i>not <\/i><\/b>pre-dilute in buffer (e.g. PBS) as this will lead to precipitation of MPLA. To yield a 100\u03bcg\/ml (1,000-100x) stock solution add 100\u03bcl of MPLA to 900\u03bcl endotoxin-free sterile\u00a0 ddWater (Cat. No.: IAX-900-002) (<b><i>not <\/i><\/b>PBS) and mix well. Ready-made solution is cell culture-grade.<\/p>\n<p><b>Stability <\/b><br \/>\nStable for at least 2 years after receipt when stored at +4\u00b0C.<\/p>\n<p>&nbsp;<\/p>\n<p><b>We ensure that our products fulfill the following:<\/b><\/p>\n<ul>\n<li>Qualified Purity &amp; Activity<\/li>\n<li>High potency TLR4-specific Ligand<\/li>\n<li>Ultrapure (no detectable protein, RNA and DNA)<\/li>\n<li>Tested on TLR4 KO murine macrophages<\/li>\n<li>Standardised Aqueous Sterile Solution<\/li>\n<li>No purification or hazardous solubilisation<\/li>\n<li>Excellent lot-to-lot consistency<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Product Size 250\u00b5g:\u00a0\u00a3100.91 500\u00b5g: \u00a3134.55 1mg: \u00a3201.82 &nbsp; Product Number 250\u00b5g: IAX-100-002-C250 500\u00b5g: IAX-100-002-C500 1mg: IAX-100-002-M001 &nbsp; Source Monophosphoryl Lipid A [MPLA] derived from S. minnesota R595 (Re) TLRpure\u2122 LPS (bio-synthetic). TLRpure\u2122 No detectable TLR4 independent activity: standardised potent TLR4-specific agonist. Purity \u226599.9%. No detectable DNA, RNA and protein traces. Purification Method R-form (mutant\/rough) LPS [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":49,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-108","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wp.innaxon.co.uk\/?page_id=108\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution -\" \/>\n<meta property=\"og:description\" content=\"Product Size 250\u00b5g:\u00a0\u00a3100.91 500\u00b5g: \u00a3134.55 1mg: \u00a3201.82 &nbsp; Product Number 250\u00b5g: IAX-100-002-C250 500\u00b5g: IAX-100-002-C500 1mg: IAX-100-002-M001 &nbsp; Source Monophosphoryl Lipid A [MPLA] derived from S. minnesota R595 (Re) TLRpure\u2122 LPS (bio-synthetic). TLRpure\u2122 No detectable TLR4 independent activity: standardised potent TLR4-specific agonist. Purity \u226599.9%. No detectable DNA, RNA and protein traces. Purification Method R-form (mutant\/rough) LPS [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wp.innaxon.co.uk\/?page_id=108\" \/>\n<meta property=\"article:modified_time\" content=\"2018-11-30T14:28:29+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wp.innaxon.co.uk\/?page_id=108\",\"url\":\"https:\/\/wp.innaxon.co.uk\/?page_id=108\",\"name\":\"Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution -\",\"isPartOf\":{\"@id\":\"https:\/\/wp.innaxon.co.uk\/#website\"},\"datePublished\":\"2018-11-30T14:24:45+00:00\",\"dateModified\":\"2018-11-30T14:28:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/wp.innaxon.co.uk\/?page_id=108#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wp.innaxon.co.uk\/?page_id=108\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/wp.innaxon.co.uk\/?page_id=108#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/wp.innaxon.co.uk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TLR4 Specific Agonists Lipopolysaccharides (LPS), Lipid A, MPLA\",\"item\":\"https:\/\/wp.innaxon.co.uk\/?page_id=49\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wp.innaxon.co.uk\/#website\",\"url\":\"https:\/\/wp.innaxon.co.uk\/\",\"name\":\"\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wp.innaxon.co.uk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wp.innaxon.co.uk\/?page_id=108","og_locale":"en_GB","og_type":"article","og_title":"Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution -","og_description":"Product Size 250\u00b5g:\u00a0\u00a3100.91 500\u00b5g: \u00a3134.55 1mg: \u00a3201.82 &nbsp; Product Number 250\u00b5g: IAX-100-002-C250 500\u00b5g: IAX-100-002-C500 1mg: IAX-100-002-M001 &nbsp; Source Monophosphoryl Lipid A [MPLA] derived from S. minnesota R595 (Re) TLRpure\u2122 LPS (bio-synthetic). TLRpure\u2122 No detectable TLR4 independent activity: standardised potent TLR4-specific agonist. Purity \u226599.9%. No detectable DNA, RNA and protein traces. Purification Method R-form (mutant\/rough) LPS [&hellip;]","og_url":"https:\/\/wp.innaxon.co.uk\/?page_id=108","article_modified_time":"2018-11-30T14:28:29+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/wp.innaxon.co.uk\/?page_id=108","url":"https:\/\/wp.innaxon.co.uk\/?page_id=108","name":"Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution -","isPartOf":{"@id":"https:\/\/wp.innaxon.co.uk\/#website"},"datePublished":"2018-11-30T14:24:45+00:00","dateModified":"2018-11-30T14:28:29+00:00","breadcrumb":{"@id":"https:\/\/wp.innaxon.co.uk\/?page_id=108#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wp.innaxon.co.uk\/?page_id=108"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/wp.innaxon.co.uk\/?page_id=108#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/wp.innaxon.co.uk\/"},{"@type":"ListItem","position":2,"name":"TLR4 Specific Agonists Lipopolysaccharides (LPS), Lipid A, MPLA","item":"https:\/\/wp.innaxon.co.uk\/?page_id=49"},{"@type":"ListItem","position":3,"name":"Monophosphoryl Lipid A [MPLA] (bio-synthetic) from S. minnesota R595 (Re) TLRpure Sterile Solution"}]},{"@type":"WebSite","@id":"https:\/\/wp.innaxon.co.uk\/#website","url":"https:\/\/wp.innaxon.co.uk\/","name":"","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wp.innaxon.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=\/wp\/v2\/pages\/108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=108"}],"version-history":[{"count":1,"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=\/wp\/v2\/pages\/108\/revisions"}],"predecessor-version":[{"id":109,"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=\/wp\/v2\/pages\/108\/revisions\/109"}],"up":[{"embeddable":true,"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=\/wp\/v2\/pages\/49"}],"wp:attachment":[{"href":"https:\/\/wp.innaxon.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}